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Abstract: Depression is one of the most prevalent mental diseases worldwide. Patients with psy-
chiatric diseases often have a history of childhood neglect, indicating that early-life experiences
predispose to psychiatric diseases in adulthood. Two strong models were used in the present study:
the maternal separation/early deprivation model (MS) and the chronic mild stress model (CMS).
In both models, we found changes in the expression of a number of genes such as Creb and Npy.
Strikingly, there was a clear regulation of expression of four genes involved in the AP-1 complex:
c-Fos, c-Jun, FosB, and Jun-B. Interestingly, different expression levels were observed depending on
the model, whereas the combination of the models resulted in a normal level of gene expression.
The effects of MS and CMS on gene expression were associated with distinct histone methyla-
tion/acetylation patterns of all four genes. The epigenetic changes, like gene expression, were also
dependent on the specific stressor or their combination. The obtained results suggest that single
life events leave a mark on gene expression and the epigenetic signature of gene promoters, but a
combination of different stressors at different life stages can further change gene expression through
epigenetic factors, possibly causing the long-lasting adverse effects of stress.
Keywords: depression; epigenetics; maternal separation; chronic mild stress
1. Introduction
Depression is one of the most costly and prevalent mental diseases worldwide. It is
predicted to be the leading cause of disease burden worldwide in 2030 [1]. Even though
this disease can be cured when detected early, many people do not seek help due to
stigmatization or limited access to specialized health service. Only a very small portion of
people with depression are diagnosed and undergo treatment. The existing treatment is
unfortunately not very effective. Only about 20% of patients receiving cognitive behavioral
therapy and 30% of those receiving antidepressants alone will be cured by the treatment [2].
Early-life adverse experiences have been implicated as predisposing factors for psychi-
atric diseases in adulthood [3], since patients often have a history of childhood neglect [4,5].
Even though the risk of disease increases immediately after exposure to these stressful
events, the effects can persist over the life course. Rodent and primate studies have
shown that the very early postnatal period is of specific importance during development.
The mother–pup relationship at this stage is key to normal development, while distur-
bances can have profound long-lasting effects on behavior in adulthood [6]. A disturbed
Hypothalamic–Pituitary–Adrenal (HPA) axis was suggested as a potential underlying
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cause of the resulting pathophysiology. Several studies have shown that early-life stress
induces a long-lasting hyperactive HPA axis [7]. Henningsen et al., 2012 described the
effect of maternal care on the response to chronic mild stress (CMS) in the adult rat. A
low level of maternal care, as measured by five different types of behavior, predisposed
rats to higher stress susceptibility. Moreover, it was documented that CMS increased the
corticosterone response [8].
It is well established that genetic factors are implicated in the etiology of depression.
Depression, in terms of major depressive disorder (MDD), runs in families. People in these
families have therefore significantly increased risk of having a relative with the disease [9].
In the present study, we chose to use the maternal separation/early deprivation model of
early-life stress to test our hypothesis that early-life stressors such as disturbances of this
familiar link may contribute to depression in adulthood. A large number of studies have
used this model to study the long-lasting effects of this type of early-life deprivation on
adult behavior (reviewed in [10]). These studies have shown that rats exposed to maternal
separation as pups permanently maintained high anxiety-like behavior [11] that elicited a
depression-like syndrome [12].
There are several studies suggesting a correlation between external environmental
factors and cellular responses through epigenetics factors. DNA methylation was investi-
gated in rats and humans as a main epigenetic factor playing a role in translating childhood
adversity into a depressive phenotype. It was shown that DNA methylation changes
occurred both in the hippocampus on the gene promoter of glucocorticoid receptor (GR,
NR3C1), spreading throughout the 7 million base-long genomic locus on chromosome
18 [13], and systemically, as shown by T cell analysis [6]. These epigenetic changes also
included histone modifications [13] and were responsible for a changed expression of GR
(and other) gene, thereby suggesting that these aberrations were causing depression in
adult life. The epigenetic events related to early-life adversity first shown in rats [14] are
translatable to humans, as suggested by several studies. Changes in DNA methylation
were shown to be associated with child abuse [15] and early-life socio-economic position
in humans [16]. It is therefore highly relevant to use animal models to study mechanisms
related to depression.
The present study was conducted on rats to allow comparisons with several important
articles in the field. Our two main aims were: (1) to investigate whether exposure of rats to
maternal separation (MS) would predispose the offspring to increased stress susceptibility
as measured by sucrose intake after exposure to CMS; (2) to determine whether a potential
effect of maternal separation was associated with distinct epigenetic pattern(s).
2. Materials and Methods
2.1. Animals and Treatment
The experiments were conducted on 35 timed-pregnant Wistar rats (Taconic MB),
arrived at the facility when they were 14 days in the gestation period. Dams were indi-
vidually housed and maintained under standard laboratory conditions (relative humidity
40% ± 5%, light/dark cycle 6.00–18.00, food and water ad libitum). Pups were assigned to
one of two rearing conditions: (1) standard facility conditions with handling of the pups
twice a week during routine cage changes; (2) daily 180 min MS from p2 to p14, including
both starting and final day. During separation, each dam was removed from the home
cage and placed in an adjacent identical cage until the end of the separation period. Pups
were thereafter removed as complete foster litters and placed into an empty cage that was
transferred to an adjacent temperature-regulated room to make sure that the pups did not
suffer from hypothermia. At three weeks of age, males were selected and placed in groups
of 3–4 rats in a standard cage (females were not used in the following experiments, due
to potential issues with the estrous cycle affecting the readouts, thus increasing variations
and ultimately demanding a higher number (n) of experimental subjects).
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2.2. Sucrose Consumption Test
One of the major symptoms in clinical depression is ’anhedonia’, which is charac-
terized by a decreased ability to feel pleasure in activities that are normally pleasurable.
In rodents, sucrose consumption is used as a behavioral readout to quantify the hedonic
state and is interpreted as a measure of reward sensitivity corresponding to the ability of
humans to feel pleasure [17]. At five weeks of age, rats were placed in individual cages
and trained to co sume a palatable sucrose solution (1.5%). The training continued for
5 weeks; the sucros test was conducted twice a week during the first 3 weeks and o ce a
week during the last 2 w eks. Th animals were food- and water-d prived 14 h before the
test, which consisted of 1 h of free access to a bottle containing a sucrose solution. Sucros
consumption was measured by weighing the bottles at the eginning nd at the end of
the test. During the stress period, the sucrose consumption test w s performed once a
week. Independent of the sucrose consumption test, water intake was monitored once
a week by weighing the water bottles before and after a 24 h period. Rats with a mean
sucrose intake below 8.5 g were designated as innate low drinkers and were not used for
further experiments.
Baseline sucrose consumption was defined as the mean sucrose consumption during
three sucrose tests conducted before stress initiation. Rats were allocated into experimental
groups based on their baseline sucrose intake. The maternally separated and control
rats were divided into control and stress groups. Following exposure to stress, rats were
characterized as anhedonic (characterized by over 30% within-subject decrease in sucrose
intake) or resilient (characterized by less than 10% within-subject decrease in sucrose
J. Pers. Med. 2021, 11, 209 4 of 11
intake). Rats not corresponding to either criterion were excluded from further experiments.
Student’s t-test was used to compare the mean sucrose intake of rats exposed to MS
compared to controls before MS rats were divided in the control and CMS groups. The
sucrose data for the groups assigned to the epigenetic studies were analyzed using a
one-way ANOVA approach. This was followed by planned comparisons of the predicted
means to compare the levels of the selected effect.
When combining MS and CMS, the following experimental groups were investigated
(n = 6): (1) Control; (2) MS; (3) CMS; (4) Anhedonic MS/CMS; (5) Resilient MS/CMS
(Table 1).
2.3. Tissue Preparation
Animals were sacrificed at the age of 16–17 weeks. Following decapitation, the brains
were swiftly removed, and the ventral hippocampi dissected and snap-frozen in liquid
nitrogen. All samples were stored at −80 ◦C until further use. The hippocampi from the
right hemisphere were used for expression analysis, whereas the hippocampi from the left
hemisphere of the same animals were used for epigenetic analysis.
2.4. Expression Analysis
Total DNA and RNA was isolated from the right hippocampi by the AllPrep DNA/RNA
Mini Kit (Qiagen) according to the manufacturer’s protocol.
For the experiment, 60 ng of DNase-treated RNA was reverse-transcribed using the
RevertAidTM Premium First Strand cDNA Synthesis Kit (Fermentas) according to the
manufacturer’s protocol. We used 1 µL of cDNA for qPCR, with Brilliant II SYBR Green
QPCR Master Mix and 0.5 µM of each primer. The reactions were run in an Mx3000PTM
QPCR System (Stratagene) for 40 cycles: 95 ◦C for 30 s, 60 ◦C for 30 s. All samples were
run in duplicates, and the Actb gene was used for normalization. The Pfaffl method was
used for quantification [18]. Statistical analysis was done by One-way ANOVA, followed
by Tukey’s post hoc test. Statistical analyses were performed using the GraphPad Prism
5.0 software.
Primers used: Actb 5′AAGGGACACCGTAGAGGGGTGGAGC 3′, 5′ CAGGAGCGT-
GCCCACGAGTGTCTAC 3′; Creb 5′CAGTTCAAGCCCAGCCACAGATTGC 3′, 5′CATGG-
ACCTGGACTGTCTGCCCATT 3′; Npy 5′CATGGCCAGATACTACTCCGCTCTGCGA3′,
5′AGCCTTGTTCTGGGGGCATTTTCTGTGC 3′; c-Fos 5′GGTCACAGAGCTGGAGCCCC-
TGTGC 3′, 5′TCGTTGCTGCTGCTGCCCTTTCGGT 3′; c-Jun 5′CCTCAACGCCTCGTTCCT-
CCAGTC 3′, 5′CGTGAGAAGGTCCGAGTTCTTGGCT 3′; FosB 5′GTCTTCGGTGGACTCC-
TTCGGCAGT 3′, 5′GTCCTGGCTGGTTGTGATTGCGGTG 3′; JunB 5′GCTGTCAAGTACT-
GCCGGCCTCCTA 3′, 5′GTGTCCGTATGGAGCAAGGGAGGCT 3′.
2.5. Chromatin Immunoprecipitation
Native chromatin immunoprecipitation (NChIP) was performed as previously de-
scribed [19]. In brief, a single hippocampus was disrupted by knife homogenization, and
the cells were lysed. Micrococcocal nuclease (MNase) (Sigma Aldrich) was used to digest
chromatin followed by nucleosome extraction by overnight dialysis. Antibodies raised
against the desired histone modification (H3K4me3 (ab8580, Abcam), H3K9me3 (ab8898,
Abcam), H4ac antibody (06-866, Upstate/Millipore) were added to the nucleosomes for
overnight incubation. Protein A-coated magnetic beads (Life Technologies) were added for
precipitation of the antibody–nucleosome complexes. Rabbit serum was used as control
(mock). The beads were washed, the complexes were eluted, and DNA was purified
by the QIAquick PCR purification kit (Qiagen) according to the manufacturer’s proto-
col. Then, 1 µL of eluted DNA and the Luminaris qPCR Master Mix (Thermo Scientific)
with 0.5 µM of each primer were used in a qPCR reaction. The reactions were run in a
Mx3000PTM QPCR System (Stratagene) for 40 cycles: 95 ◦C for 30 s, 60 ◦C for 30 s, and
72 ◦C for 30 s. All samples were run in triplicates. Actb and Hist1H2BA genes were used
for normalization purpose.
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The Pfaffl method was used for quantification [18]. Statistical analysis was performed
on log-transformed data by one-way ANOVA, followed by Tukey’s post hoc test. Statistical
analyses were performed using the GraphPad Prism 5.0 software.
Primers used: Actb 5′GTGGCACCACCATGTACCCAGGCAT3′, 5′ACTACAGGGCTG-
ACCACACCCCACT3′; c-Fos 5′TTACTACGTCATGAGCGGAACAGAG3′, 5′AGGTGAAA-





3. Results and Discussion
The animals were subjected to the MS protocol in early life, followed by CMS in
adulthood, and sucrose intake was measured once a week from age 5 weeks, as a proxy
for depression-like behavior. A comparison of baseline sucrose intakes (before MS rats
were divided in control and CMS groups) showed a significant effect of MS alone on
baseline sucrose intake (p = 0.009), with rats exposed to MS showing significantly decreased
sucrose intake. The biggest anhedonic-like effect measured by the sucrose intake test
was observed after the induction of CMS, regardless of MS, as shown by comparison
with the control group (CMS (p = 0.04) and MS/CMS-A (p = 0.02)). As expected, the
resilient group (MS/CMS-R) exhibited a sucrose intake similar to that of the control group
and significantly different from that of the anhedonic-like MS/CMS-A group (p = 0.01)
(Figure 1a). Furthermore, we evaluated the effect of CMS by determining the number
of rats with different phenotypes in groups exposed to MS/CMS or CMS alone. The
fraction of anhedonic-like rats was larger in the MS/CMS group compared to the CMS
group, whereas the fraction of resilient rats was larger in the CMS group compared to the
MS/CMS group (Figure 1b).
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in the CMS or CMS-MS group after seven weeks of CMS.
Maternal separation and/or CMS cause either temporal or long-lasting changes in
gene expression [13]. We looked at several genes relevant for neural activation and tran-
scriptional activity such as Creb, Npy, and the activator protein-1 (AP-1) complex consisting
of the immediate early genes (IEGs) c-Fos, c-Jun, Fos-B, Jun-B. The AP-1 complex can form
in different ways. It can either be a homodimer of JUN family proteins or a heterodimer of
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JUN/FOS family proteins. It is therefore interesting that there seemed to be a concerted
expression regulation across three IEGs, i.e., c-Fos, Jun-B, and Fos-B (Figure 2).
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Figure 2. Expression of genes coding for the AP-1 complex: (a) c-Fos; (b) Fos-B; (c) c-Jun; (d) Jun-B Resilient: group of
animals not exhibiting anhedonia after stress treatment. Data shown as mean fold change expression +/− SEM, normalized
according to the expression of ActB mRNA, * = p < 0.05, ** = p < 0.02, *** = p ≤ 0.01.
The expression levels of Jun-B, Fos-B, and c-Fos displayed a si ilar pattern in the
investigated groups. They remained unchanged in t the anhedonic-like and the resili nt
MS/CMS groups, whereas they were decr in the MS group and increas d in the CMS
group. On the other hand, the expression of c-Jun displayed a completely different pattern,
remaining unchanged in the MS and MS/CMS-R groups and increasing in the CMS and
MS/CMS-A groups. A significant 38% (p < 0.01) increase in c-Jun mRNA levels in the
MS/CMS-A group (Figure 2c) might be an anhedonic trademark, since it was observed also
in the CMS group, but not in the MS and the MS/CMS-R groups, which showed unaltered
expression of c-Jun. The differential expression of c-Jun with respect to the other IEGs may
be traced back to normal cellular physiology of the hippocampus. In this brain region,
c-Jun is strongly expressed in the dentate gyrus, whereas none of the re aining IEGs is
expressed [20]. O e may therefore speculate that the variation is due to differential effects
of stress on the transcriptional machinery involved in the production of AP-1 complexes.
Interestingly, the Creb gene, coding for the constitutive transcription factor CREB, was
significantly upregulated by MS and CMS as well as by their combination (Figure 3a).
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CREB is involved in the transcription of Fos/Jun gene families. It is important to
bear in mind that CREB can either activate or repress gene expression depending on the
phosphorylation state of Ser-133 by protein kinase A (PKA) [21], being an activator in the
phosphorylated state and a repressor in the dephosphorylated form [20]. We also tested
the expression of Npy, which is independent of Fos/Jun family and codes for neuropeptide
Y (NPY) involved in various physiological and homeostatic processes in the central and
peripheral n rvous systems. NPY antagonizes the effect of stress through multipl actions
in the brain [22]. It is therefore noteworthy that Npy was significantly upregulated in our
models, in a pattern similar to that of CREB (Figure 3b). CREB has been shown to regulate
Npy gene expression in the amygdala [23] and hippocampus [24]. Both genes increased
significantly in the anhedonic animals, but their expression did not fall to control levels
in the resilient animals, suggesting that Creb and Npy expression could be involved in
stress protection.
Since MS and stress are very strong environmental factors influencing gene expression,
we investigated several histone modifications to identify changes that could explain the
synchronized regulation of Fos and Jun: histone H4 ac tylation (H4ac), histone H3 lysin
9 trimethylation (H3K9m 3), and histone H3 lysine 4 trimethylation (H3K4me3). H4ac and
H3K4me3 are found on activated gene promoters, whereas histone H3K9me3 is involved in
gene silencing. Two of the histone modifications, i.e., H4ac and H3K9me3, revealed specific
patterns. Association between gene promoters and the activating H4ac modification
was increased in the MS group for all investigated IEGs, while it was decreased in the
MS/CMS-A group. Interestingly, it remained unchanged in the CMS and MS/CMS-R
groups (Figure 4).
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The gene expression pattern was not consistent with the H4Ac modification of the
promoters, possibly due to the presence of the repressing H3K9me3 histone modification
that showed a similar, yet more pronounced, pattern for all investigated Fos/Jun genes
(Figure 5). The last investigated modification, H3K4me3, did not show any specific patterns
that could explain the similar expression of the gene family (Supplementary Figure S1). It is
clear hat MS caused a massive increase in Fos/Jun expr ssio (except for c-Jun) that cannot
be explained by the st tic picture of histone modifications affecting the ge e promoters.
Nevertheless, a pattern could be observed suggesting that CMS had an opposite effect on
the epigenetic marks compared to MS (compare Figures 4 and 5). Furthermore, the levels of
histone modifications related to the c-Fos promoter remained high in the resilient group of
animals, despite c-Fos expression falling to the level of the control group (Figures 4a and 5a)
Numerous significant differences were observed between the anhedonic and the
re t MS/CMS groups. These may reveal mechan sms important for susceptibility
to CMS, which can explain the two distinct phenotypes. Acetylation of H4 (H4ac) was
consistently decreased for all IEGs except for Fos-B in the MS/CMS-A group. In contrast,
the MS and MS/CMS-R groups showed increased association of H4ac with gene promot-
ers (Figure 4). This could spark the idea that H4ac is an important coping mechanism
for the resilient phenotype. Similar to H4Ac, the MS/CMS-R group showed increased
levels of H3K9me3 than the MS/CMS-A group, except for c-Jun for which the change in
H3K9me3 did not reach statistical significance. Interestingly, and in contrst to H4Ac, the
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CMS group displayed decreased association with H3K9me3, compared to controls. This
decreased association may be involved in a mechanism by which CMS causes anhedo-
nia, since both the non-anhedonic groups (MS and MS/CMS-R) displayed significantly
increased association with H3K9me3. This epigenetic makeup has a clear influence on the
expression of AP-1 complex genes, which were simultaneously elevated in the CMS group
(Figure 2). Taken together, elevated mRNA expression of Fos/Jun family genes could be
important in the establishment of the anhedonic phenotype, whereas elevated H4ac and
H3K9me3 may be important for the establishment of the resilient phenotype.
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An open question in depression is whether it is a disease of the brain or a systemic
disease. As our group has shown in the past [25], there is a pronounced metabolic imbalance
in depressed animals. This metabolic imbalance is coupled not only to depression but also
to inflammation, as shown in the same article. In this study, we can now couple epigenetic
regulation not only to depression and MS-induced sensitivity to depression but also to
i flammation, since the Fos/Jun g ne family is not brain-specific but is expressed i many
tissues. It would be interesting to investigate whether changes in gene expression can be
detected in other organs, e.g., the immune system. This would be of great importance [26],
as it is known that immunity is compromised in individuals with stress and depression.
Furthermore, interestingly, c-Jun is also involved in metabolism regulation [27]. This may
suggest alternative treatment options. Whether Fos/Jun expression changes in the immune
system und r stress and depression and whether p tential expression differences could
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serve as a marker of predisposition to depression in the context of personalized medicine
remain to be shown.
4. Conclusions
Exposure of rats to MS alone was enough to induce depressive-like behavior (anhedo-
nia), measured by sucrose intake, but the application of CMS significantly increased the
anhedonic behavior. A number of genes were regulated in anhedonic and resilient animals,
including immediate early genes of the AP-1 complex, i.e., c-Fos, c-Jun, FosB, and JunB.
Changes in AP-1 complex genes expression were associated with concerted epigenetic
regulation, providing one more link between environment and gene expression for the
appearance of pathology. This opens new questions for research in the field that should
involve the immune system and metabolism.
Supplementary Materials: The following are available online at https://www.mdpi.com/2075-442
6/11/3/209/s1, Figure S1: Association of histone H3 Lysine 4 trimethylation acetylation (H3K4me3)
with different IEG promoters. MS- maternal separation, CMS- chronic mild stress, MS/CMS- chronic
mild stress on the MS rats, Resilient- group of animals not exhibiting anhedonia after stress treatment.
Results presented as fold change over a control gene promoter +/− SEM (ActB). * = p < 0.05,
** = p < 0.01, *** = p ≤ 0.001.
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